ARCHIVES

Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | March 20, 2009

Download PDF Visit The Full Archive

Related Articles

DCCR Plans Three Multiple Contracts In Pain Control

February 17, 1978

ONS Votes to Push Congress on DRGs

June 1, 1984

Three Genetics Pioneers Win Nobel Prize

October 11, 2002

BCF Members Miffed When NCI Refuses To Delay New Breast Cancer RFA To Allow Them Chance To Study It

April 8, 1983

Robert Cook-Deegan On Implications of Appelate Court Ruling In Myriad Case Ruling

August 5, 2011

NCI Programs: Advisors Approve Recompetition of Phase II Contracts

July 9, 1999